Combination Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients with NSCLC Receiving Carboplatin-Based Chemotherapy

PURPOSE: The incidence of delayed chemotherapy-induced nausea and vomiting (CINV) in patients with non-small cell lung cancer (NSCLC) receiving carboplatin (CBDCA)-based chemotherapy (CBDCA + pemetrexed or paclitaxel) has not been clearly described. Therefore, we attempted to evaluate whether delaye...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimokawa, Mototsugu, Haratake, Naoki, Takada, Kazuki, Toyokawa, Gouji, Takamori, Shinkichi, Mizuki, Fumitaka, Takenaka, Tomoyoshi, Hayashi, Toshinobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470117/
https://www.ncbi.nlm.nih.gov/pubmed/36110158
http://dx.doi.org/10.2147/CMAR.S370961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470117/
https://www.ncbi.nlm.nih.gov/pubmed/36110158
http://dx.doi.org/10.2147/CMAR.S370961

Ejemplares similares